ECM1 expression correlates adversely with patient outcome in several types of cancer [5], and ECM1 was expressed at relatively high levels in BT-474 TR cells, at both the mRNA and protein levels (Additional file 2: Figures S1E and S1F). The gene discussed is ECM1; the disease is cancer.